INS and hereditary elliptocytosis: The joint effect analysis displayed that the risk of developing HE associated with levofloxacin was increased when used in combination with insulin (aOR = 8.42, 95% CI: 1.91–37.00) or sulfonylurea (aOR = 3.56, 95% CI: 1.12–11.33) (Table 5).